Cargando…

Anti-Tumor Immunogenicity of the Oncolytic Virus CF33-hNIS-antiPDL1 against Ex Vivo Peritoneal Cells from Gastric Cancer Patients

We studied the immunotherapeutic potential of CF33-hNIS-antiPDL1 oncolytic virus (OV) against gastric cancer with peritoneal metastasis (GCPM). We collected fresh malignant ascites (MA) or peritoneal washings (PW) during routine paracenteses and diagnostic laparoscopies from GC patients (n = 27). Ce...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Zhifang, Yang, Annie, Chaurasiya, Shyambabu, Park, Anthony K., Kim, Sang-In, Lu, Jianming, Valencia, Hannah, Fong, Yuman, Woo, Yanghee
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10532045/ https://www.ncbi.nlm.nih.gov/pubmed/37762490 http://dx.doi.org/10.3390/ijms241814189

Ejemplares similares

PET imaging and treatment of pancreatic cancer peritoneal carcinomatosis after subcutaneous intratumoral administration of a novel oncolytic virus, CF33-hNIS-antiPDL1
por: Zhang, Zhifang, et al.
Publicado: (2021)

A comprehensive preclinical study supporting clinical trial of oncolytic chimeric poxvirus CF33-hNIS-anti-PD-L1 to treat breast cancer
por: Chaurasiya, Shyambabu, et al.
Publicado: (2021)

An Oncolytic Poxvirus Encoding hNIS, Shows Antitumor Efficacy and Allows Tumor Imaging in a Liver Cancer Model
por: Chaurasiya, Shyambabu, et al.
Publicado: (2023)

Oncolytic poxvirus CF33-hNIS-ΔF14.5 favorably modulates tumor immune microenvironment and works synergistically with anti-PD-L1 antibody in a triple-negative breast cancer model
por: Chaurasiya, Shyambabu, et al.
Publicado: (2020)

CF33-hNIS-anti-PD-L1 oncolytic virus followed by trastuzumab-deruxtecan in a patient with metastatic triple negative breast cancer: a case study
por: Yuan, Yuan, et al.
Publicado: (2023)

A Novel Chimeric Poxvirus Encoding hNIS Is Tumor-Tropic, Imageable, and Synergistic with Radioiodine to Sustain Colon Cancer Regression
por: Warner, Susanne G., et al.
Publicado: (2019)

Development of the oncolytic virus, CF33, and its derivatives for peritoneal-directed treatment of gastric cancer peritoneal metastases
por: Yang, Annie, et al.
Publicado: (2023)

Peritoneal-directed chimeric oncolytic virus CF17 prevents malignant ascites and improves survival in gastric cancer peritoneal metastases
por: Yang, Annie, et al.
Publicado: (2023)

Toward comprehensive imaging of oncolytic viroimmunotherapy
por: Chaurasiya, Shyambabu, et al.
Publicado: (2021)

Oncolytic Virotherapy for Cancer: Clinical Experience
por: Chaurasiya, Shyambabu, et al.
Publicado: (2021)

SPECT/CT Imaging of hNIS -Expression after Intravenous Delivery of an Oncolytic Adenovirus and (131)I
por: Rajecki, Maria, et al.
Publicado: (2012)

Optimizing Oncolytic Viral Design to Enhance Antitumor Efficacy: Progress and Challenges
por: Chaurasiya, Shyambabu, et al.
Publicado: (2020)

Vitamin D as a Primer for Oncolytic Viral Therapy in Colon Cancer Models
por: Kim, Sang-In, et al.
Publicado: (2020)

A chimeric poxvirus with J2R (thymidine kinase) deletion shows safety and anti-tumor activity in lung cancer models
por: Chaurasiya, Shyambabu, et al.
Publicado: (2019)

Fluorescent imaging for cancer therapy and cancer gene therapy
por: Woo, Yanghee, et al.
Publicado: (2021)

A Novel Oncolytic Chimeric Orthopoxvirus Encoding Luciferase Enables Real-Time View of Colorectal Cancer Cell Infection
por: O’Leary, Michael P., et al.
Publicado: (2018)

Novel oncolytic chimeric orthopoxvirus causes regression of pancreatic cancer xenografts and exhibits abscopal effect at a single low dose
por: O’Leary, Michael P., et al.
Publicado: (2018)

Codon-optimized Human Sodium Iodide Symporter (opt-hNIS) as a Sensitive Reporter and Efficient Therapeutic Gene
por: Kim, Young-Hwa, et al.
Publicado: (2015)

Priming stroma with a vitamin D analog to optimize viroimmunotherapy for pancreatic cancer
por: Kim, Sang-In, et al.
Publicado: (2022)

Oncolytic Virotherapy versus Cancer Stem Cells: A Review of Approaches and Mechanisms
por: Chaurasiya, Shyambabu, et al.
Publicado: (2018)

hTPO和hNIS共转染肺癌细胞系H460介导放射性碘摄取的研究
Publicado: (2010)

Oncolytic Herpes Simplex Virus Prevents Premalignant Lesions from Progressing to Cancer
por: Woo, Yanghee, et al.
Publicado: (2019)

The use of the NIS reporter gene for optimizing oncolytic virotherapy
por: Miller, Amber, et al.
Publicado: (2016)

In vitro study on human umbilical cord mesenchymal stem cells transfected with lentivirus-mediated hNIS-EGFP dual reporter gene and co-labeled with superparamagnetic iron oxide
por: Meng, Yu, et al.
Publicado: (2018)

Molecular imaging of oncolytic viral therapy
por: Haddad, Dana, et al.
Publicado: (2015)

Identification of core aberrantly expressed microRNAs in serous ovarian carcinoma
por: Chen, Steven F., et al.
Publicado: (2018)

2-Aminopurine Enhances the Oncolytic Activity of an E1b-Deleted Adenovirus in Hepatocellular Carcinoma Cells
por: Sharon, David, et al.
Publicado: (2013)

The Oncolytic Activity of Myxoma Virus against Soft Tissue Sarcoma Is Mediated by the Overexpression of Ribonucleotide Reductase
por: Woo, Yanghee, et al.
Publicado: (2021)

The combination of ANT2 shRNA and hNIS radioiodine gene therapy increases CTL cytotoxic activity through the phenotypic modulation of cancer cells: combination treatment with ANT2 shRNA and I-131
por: Choi, Yun, et al.
Publicado: (2013)

Pharmacological tumor PDL1 depletion with chlorambucil treats ovarian cancer and melanoma: improves antitumor immunity and renders anti-PDL1-resistant tumors anti-PDL1-sensitive through NK cell effects
por: Bai, Haiyan, et al.
Publicado: (2023)

Engineered extracellular vesicles for concurrent Anti-PDL1 immunotherapy and chemotherapy
por: Chen, Yundi, et al.
Publicado: (2021)

Viroimmunotherapy for Colorectal Cancer: Clinical Studies
por: Chaurasiya, Shyambabu, et al.
Publicado: (2017)

PDL1 Expression on Plasma and Dendritic Cells in Myeloma Bone Marrow Suggests Benefit of Targeted anti PD1-PDL1 Therapy
por: Sponaas, Anne-Marit, et al.
Publicado: (2015)

Resistance Mechanisms of Anti-PD1/PDL1 Therapy in Solid Tumors
por: Lei, Qingyang, et al.
Publicado: (2020)

Anti-PDL1 effect in squamous non-small cell lung cancer
por: Rahouma, Mohamed, et al.
Publicado: (2020)

Immunotherapy for Soft Tissue Sarcomas: Anti-PD1/PDL1 and Beyond
por: Fazel, Mina, et al.
Publicado: (2023)

Dual-Isotope SPECT Imaging with NIS Reporter Gene and Duramycin to Visualize Tumor Susceptibility to Oncolytic Virus Infection
por: Zhang, Lianwen, et al.
Publicado: (2019)

Oncolytic viral therapy for pancreatic cancer: current research and future directions
por: Ady, Justin W, et al.
Publicado: (2014)

From Benchtop to Bedside: A Review of Oncolytic Virotherapy
por: Choi, Audrey H., et al.
Publicado: (2016)

Germline biomarkers predict toxicity to anti-PD1/PDL1 checkpoint therapy
por: Weidhaas, Joanne, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_t3o88044u8bjshsg5o1muuqd5j